@prefix bf: <http://id.loc.gov/ontologies/bibframe/> .
@prefix bflc: <http://id.loc.gov/ontologies/bflc/> .
@prefix mads: <http://www.loc.gov/mads/rdf/v1#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://stage.bcld.info/works/804a813e-ee6b-4dec-90d6-6ee8fc4c6225> a bf:Monograph,
        bf:Text,
        bf:Work ;
    bflc:aap "Pharmacotherapy : a pathophysiologic approach" ;
    bflc:aap-normalized "pharmacotherapy:apathophysiologicapproach" ;
    bf:adminMetadata [ a bf:AdminMetadata ;
            bflc:catalogerId "Unknown" ;
            bf:date "2026-09-11" ;
            bf:descriptionAuthentication <http://id.loc.gov/vocabulary/marcauthen/pcc> ;
            bf:descriptionLanguage <http://id.loc.gov/vocabulary/languages/eng> ;
            bf:descriptionLevel <http://id.loc.gov/ontologies/bibframe-2-6-0/> ],
        [ a bf:AdminMetadata ;
            bf:agent <http://id.loc.gov/vocabulary/organizations/cbc> ;
            bf:date "2026-09-11T20:18:02.291199+00:00"^^xsd:dateTime ;
            bf:derivedFrom <http://id.loc.gov/resources/works/23975475> ;
            bf:status <http://id.loc.gov/vocabulary/mstatus/c> ] ;
    bf:classification [ a bf:ClassificationNlm ;
            bf:assigner <http://id.loc.gov/vocabulary/organizations/dnlm> ;
            bf:classificationPortion "2008 H-548" ;
            bf:status <http://id.loc.gov/vocabulary/mstatus/uba> ],
        [ a bf:ClassificationDdc ;
            bf:assigner <http://id.loc.gov/vocabulary/organizations/dlc> ;
            bf:classificationPortion "615.5/8" ;
            bf:edition "full" ;
            bf:source [ a bf:Source ;
                    bf:code "22" ] ],
        [ a bf:ClassificationNlm ;
            bf:assigner <http://id.loc.gov/vocabulary/organizations/dnlm> ;
            bf:classificationPortion "WB 330" ;
            bf:itemPortion "P5357 2008" ;
            bf:status <http://id.loc.gov/vocabulary/mstatus/nuba> ],
        [ a bf:ClassificationLcc ;
            bf:assigner <http://id.loc.gov/vocabulary/organizations/dlc> ;
            bf:classificationPortion "RM263" ;
            bf:status <http://id.loc.gov/vocabulary/mstatus/uba> ] ;
    bf:content <http://id.loc.gov/vocabulary/contentTypes/txt> ;
    bf:contribution [ a bf:Contribution ;
            bf:agent <http://id.loc.gov/rwo/agents/n88044759> ;
            bf:role <http://id.loc.gov/vocabulary/relators/ctb> ] ;
    bf:hasInstance <https://stage.bcld.info/instances/fb744ffc-626e-4354-8f3b-807ca8e57da8> ;
    bf:illustrativeContent <http://id.loc.gov/vocabulary/millus/ill> ;
    bf:language <http://id.loc.gov/vocabulary/languages/eng> ;
    bf:relation [ a bf:Relation ;
            bf:associatedResource <https://stage.bcld.info/works/7773eb4e-747e-49c4-903f-880c3d5be2d2> ;
            bf:relationship [ a bf:Relationship ;
                    rdfs:label "Print Version" ],
                <http://id.loc.gov/vocabulary/relationship/otherphysicalformat> ] ;
    bf:subject [ a bf:Topic,
                mads:Topic ;
            rdfs:label "Drug Therapy" ;
            bflc:aap-normalized "drugtherapy" ;
            bf:source <http://id.loc.gov/vocabulary/subjectSchemes/mesh> ;
            mads:authoritativeLabel "Drug Therapy" ],
        <http://id.loc.gov/authorities/subjects/sh85023041>,
        <http://id.loc.gov/authorities/subjects/sh85101683> ;
    bf:supplementaryContent <http://id.loc.gov/vocabulary/msupplcont/bibliography>,
        <http://id.loc.gov/vocabulary/msupplcont/index> ;
    bf:tableOfContents [ a bf:TableOfContents ;
            rdfs:label "Sleep disorders -- Developmental disabilities -- Diabetes mellitus -- Thyroid disorders -- Adrenal gland disorders -- Pituitary gland disorders -- Pregnancy and lactation: therapeutic considerations -- Contraception -- Menstruation-related disorders -- Endometriosis -- Hormone therapy in women -- Erectile dysfunction -- Management of benign -- Urinary incontinence -- Function and evaluation of the immune system -- Systemic lupus erythematosus and other collagen-vascular diseases -- Allergic and pseudoallergic drug reactions -- Solid-organ transplantation -- Osteoporosis and other metabolic bone diseases -- Rheumatoid arthritis -- Osteoarthritis -- Gout and hyperuricemia -- Glaucoma -- Allergic rhinitis -- Dermatologic drug reactions and self-treatable skin disorders -- Acne vulgaris -- Psoriasis -- Atopic dermatitis -- Hematopoiesis -- Anemias -- Coagulation disorders -- Sickle cell disease -- Drug-induced hematologic disorders -- Laboratory tests to direct antimicrobial pharmacotherapy -- Antimicrobial regimen selection -- Central nervous system infections -- Lower respiratory tract infections -- Upper respiratory tract infections -- Influenza -- Skin and soft-tissue infections -- Infective endocarditis -- Tuberculosis -- Gastrointestinal infections and enterotoxigenic poisonings -- Intraabdominal infections -- Parasitic diseases -- Urinary tract infections and prostatitis -- Sexually transmitted diseases -- Bone and joint infections -- Sepsis and septic shock -- Superficial fungal infections -- Invasive fungal infections -- Infections in immunocompromised patients -- Antimicrobial prophylaxis in surgery -- Vaccines, toxoids, and other immunobiologics -- Human immunodeficiency virus infection -- Cancer treatment and chemotherapy -- Breast cancer -- Lung cancer -- Colorectal cancer -- Prostate cancer -- Lymphomas -- Ovarian cancer -- Acute leukemias -- Chronic leukemias -- Multiple myeloma -- Myelodysplastic syndromes -- Skin cancer -- Hematopoietic stem cell transplantation -- Assessment of nutrition status and nutrition requirements -- Prevalence and significance of malnutrition -- Parenteral nutrition -- Enteral nutrition -- Nutritional considerations in major organ failure -- Obesity." ],
        [ a bf:TableOfContents ;
            rdfs:label "Pharmacoeconomics: principles, methods, and applications -- Health outcomes and quality of life -- Evidence-based medicine -- Documentation of pharmacy services -- Clinical pharmacokinetics and pharmacodynamics -- Pharmacogenetics -- Pediatrics -- Geriatrics -- Pharmacoepidemiology -- Clinical toxicology -- Emergency preparedness: indentification and management of biological exposures -- Emergency preparedness: identification and management of chemical and radiological exposures -- Cardiovascular testing -- Cardiopulmonary arrest -- Hypertension -- Heart failure -- Ischemic heart disease -- Acute coronary syndromes -- The arrhythmias -- Diastolic heart failure and the cardiomyopathies -- Venous thromboembolism -- Stroke -- Hyperlipidemia -- Peripheral arterial disease -- Use of vasopressors and inotropes in the pharmacotherapy of shock -- Hypovolemic shock -- Introduction to pulmonary function testing -- Asthma -- Chronic obstructive pulmonary disease -- Pulmonary hypertension -- Drug-induced pulmonary diseases -- Cystic fibrosis -- Evaluation of the gastrointestinal tract -- Gastroesophageal reflux disease -- Peptic ulcer disease -- Inflammatory bowel disease -- Nausea and vomiting -- Diarrhea, constipation, and irritable bowel syndrome -- Portal hypertension and cirrhosis -- Drug-induced liver disease -- Pancreatitis -- Viral hepatitis -- Drug therapy individualization in patients with hepatic disease or genetic alterations in drug metabolizing activity -- Quantification of renal function -- Acute renal failure -- Chronic kidney disease: progression-modifying therapies -- Chronic kidney disease: management of complications -- Hemodialysis and peritoneal dialysis -- Drug-induced kidney disease -- Glomerulonephritis -- Drug therapy individualization for patients with renal insufficiency -- Disorders of sodium and water homeostasis -- Disorders of calcium and phosphorus homestasis -- Disorders of potassium and magnesium homeostasis -- Acid-base disorders -- Evaluation of neurologic illness -- Multiple sclerosis -- Epilepsy -- Status epilepticus -- Acute management of the brain injury patient -- Parkinson's disease -- Pain management -- Headache disorders -- Evaluation of psychiatric illness -- Childhood disorders -- Eating disorders -- Alzheimer's disease -- Substance-related disorders: overview and depressants, stimulants, and hallucinogens -- Substance-related disorders: alcohol, nicotine, and caffeine -- Schizophrenia -- Depressive disorders -- Bipolar disorder -- Anxiety disorders I: generalized anxiety, panic, and social anxiety disorders -- Anxiety disorders II: posttraumatic stress disorder and obsessive-compulsive disorder --" ] ;
    bf:title [ a bf:Title ;
            bf:mainTitle "Pharmacotherapy : a pathophysiologic approach" ] .